253 related articles for article (PubMed ID: 3030295)
1. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
Tamura N; Agrawal DK; Suliaman FA; Townley RG
Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
[TBL] [Abstract][Full Text] [Related]
2. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P
Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011
[TBL] [Abstract][Full Text] [Related]
3. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
[TBL] [Abstract][Full Text] [Related]
7. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
[TBL] [Abstract][Full Text] [Related]
8. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
Hidi R; Coëffier E; Vargaftig BB
J Leukoc Biol; 1992 May; 51(5):425-31. PubMed ID: 1318347
[TBL] [Abstract][Full Text] [Related]
9. LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists.
Coëffier E; Joseph D; Vargaftig BB
Int J Immunopharmacol; 1991; 13(2-3):273-80. PubMed ID: 1649143
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
Tamura N; Agrawal DK; Townley RG
J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
[TBL] [Abstract][Full Text] [Related]
12. New method for the measurement of eosinophil migration.
Håkansson L; Westerlund D; Venge P
J Leukoc Biol; 1987 Dec; 42(6):689-96. PubMed ID: 2445885
[TBL] [Abstract][Full Text] [Related]
13. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
Casale TB; Erger RA; Little MM
Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
[TBL] [Abstract][Full Text] [Related]
15. Comparison of platelet-activating factor-induced chemotaxis of normodense and hypodense eosinophils.
Little MM; Casale TB
J Allergy Clin Immunol; 1991 Aug; 88(2):187-92. PubMed ID: 1880319
[TBL] [Abstract][Full Text] [Related]
16. Stimulus amplification by PAF and LTB4 in human neutrophils.
Baggiolini M; Dewald B
Pharmacol Res Commun; 1986 Aug; 18 Suppl():51-9. PubMed ID: 3022311
[No Abstract] [Full Text] [Related]
17. Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.
e Silva PM; Martins MA; Faria Neto HC; Cordeiro RS; Vargaftig BB
J Pharmacol Exp Ther; 1991 Jun; 257(3):1039-44. PubMed ID: 2046020
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
Erger RA; Casale TB
Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
[TBL] [Abstract][Full Text] [Related]
19. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro.
Foster AP; Lees P; Cunningham FM
Res Vet Sci; 1992 Sep; 53(2):223-9. PubMed ID: 1332153
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
